AC Immune (ACIU) Current Assets (2015 - 2026)
AC Immune (ACIU) posted quarterly Current Assets of $102.2 billion for Q1 2026, up 60314.5% year-over-year from N/an in Q1 2025, and down 15.52% quarter-over-quarter from $121.0 billion in Q4 2025.
AC Immune (ACIU) Current Assets (2015 - 2026) Analysis & Trends
AC Immune (ACIU) has reported Current Assets for 12 consecutive years, with $102.2 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 60314.5% year-over-year to $102.2 billion; the TTM figure through Mar 2026 stood at $102.2 billion (up 60314.5% YoY), while the FY2025 annual figure was $116.7 billion, up 59318.45% from the prior year.
- Current Assets slipped to $102.2 billion in Q1 2026 per ACIU's latest filing, from $121.0 billion in the prior quarter.
- Across five years, Current Assets topped out at $191.7 billion in Q1 2022 and bottomed at $97.6 million in Q3 2023.
- Historically, Current Assets has averaged $42.5 billion across 5 years, with a median of $169.2 million in 2025.
- Annual changes were most pronounced in 2022 — Current Assets sank 99.94% — and 2023, when it jumped 106012.48%.
- AC Immune's Current Assets stood at $133.0 million in 2022, then surged by 106012.48% to $141.1 billion in 2023, then slumped by 99.86% to $196.3 million in 2024, then soared by 61537.35% to $121.0 billion in 2025, then dropped by 15.52% to $102.2 billion in 2026.
- Business Quant data shows ACIU's Current Assets at $102.2 billion in Q1 2026, $121.0 billion in Q4 2025, and $142.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | 118.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 118.17 Mn |
| Mar 31, 2026 | 102.23 Bn |
| Dec 31, 2025 | 121.02 Bn |
| Sep 30, 2025 | 142.19 Mn |
| Jun 30, 2025 | 159.21 Mn |
| Mar 31, 2025 | 169.21 Mn |
| Dec 31, 2024 | 196.33 Mn |
| Sep 30, 2024 | 216.52 Mn |
| Jun 30, 2024 | 199.64 Mn |
| Mar 31, 2024 | 125.88 Mn |
| Dec 31, 2023 | 141.09 Bn |
| Sep 30, 2023 | 97.57 Mn |
| Jun 30, 2023 | 110.27 Mn |
| Mar 31, 2023 | 120.75 Mn |
| Dec 31, 2022 | 132.96 Mn |
| Sep 30, 2022 | 152.84 Mn |
| Jun 30, 2022 | 164.44 Bn |
| Mar 31, 2022 | 191.72 Bn |
| Dec 31, 2021 | 219.76 Bn |
| Sep 30, 2021 | 212.79 Bn |